Taiho Oncology, Inc.
Winny Chan currently serves as the Manager of Clinical Pharmacology & Biomarkers at Taiho Oncology, Inc., beginning in January 2024. Prior to this role, Winny Chan held positions at Astex Pharmaceuticals, Inc. from March 2021 to December 2023, progressing from Clinical Biosamples Coordinator to Senior Scientist in Clinical Pharmacology. Winny Chan's earlier experience includes a position as a Student Researcher at the University of the Pacific and various internships, including a Pharmacy Intern at Walgreens and a Volunteer Intern at VeganMed, Inc. Winny Chan's academic credentials include a Doctor of Pharmacy (Pharm.D.) from the University of the Pacific, obtained between 2014 and 2016. Additionally, Winny Chan engaged in research internships with the ACS Project SEED Program during the summers of 2012 and 2013.
This person is not in any teams
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com